Extracorporeal membrane oxygenation for end-stage heart failure

Corbin E. Goerlich, Matthew Acton, Ahmet Kilic

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for end-stage heart failure is a powerful tool to reverse acute shock and bridge a patient either to recovery, durable ventricular assist device (VAD), transplantation, or to extend a time for ongoing reevaluation of a patient’s clinical status. Patient selection is paramount. Patients without a reasonable chance for recovery or who are otherwise not candidates for advanced surgical therapy can have VA-ECMO initiation as a bridge to nowhere without an exit strategy. In this chapter, careful consideration is given to patients with heart failure requiring VA-ECMO in terms of patient selection, indications, management and auxiliary mechanical circulatory support (MCS) devices while on VA-ECMO.

Original languageEnglish (US)
Title of host publicationCardiopulmonary Bypass
Subtitle of host publicationAdvances in Extracorporeal Life Support
PublisherElsevier
Pages1243-1252
Number of pages10
ISBN (Electronic)9780443189180
DOIs
StatePublished - Jan 1 2022

Keywords

  • ECMO
  • ELSO
  • Ecpella
  • Extracorporeal Life Support Organization
  • Heart failure
  • Heartmate
  • Heartware
  • Protek Duo
  • TandemHeart
  • extracorporeal membrane oxygenation
  • impella
  • mechanical circulatory support

ASJC Scopus subject areas

  • General Agricultural and Biological Sciences
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Extracorporeal membrane oxygenation for end-stage heart failure'. Together they form a unique fingerprint.

Cite this